The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive individuals by Vogel M, Ahlenstiel G, Hintsche B, Fenske S, Trein A, Lutz T, Schürmann D, Stephan C, Khaykin P, Bickel M, Mayr C, Baumgarten A, Buggisch P, Klinker H, John C, Gölz J, Staszewski S, Rockstroh JK

Get full text

Tissue-based activation of mucosal-associated invariant T (MAIT) cells in combination ipilimumab and nivolumab checkpoint inhibitor (CI) colitis by Sasson, SC, Cheung, VTF, Gupta, T, Zaunders, JJ, Nahar, K, Munier, CM-L, Olsson-Brown, A, Ahlenstiel, G, Palendira, U, Scolyer, RA, Carlino, MS, Long, GV, Menzies, AM, Kelleher, A, Payne, M, Fairfax, B, Middleton, MR, Klenerman, P, Brain, O

Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a patholog... by Sasson, SC, Zaunders, JJ, Nahar, K, Munier, CML, Fairfax, BP, Olsson-Brown, A, Jolly, C, Read, SA, Ahlenstiel, G, Palendira, U, Scolyer, RA, Carlino, MS, Payne, MJ, Cheung, VTF, Gupta, T, Klenerman, P, Long, GV, Brain, O, Menzies, AM, Kelleher, AD